Market Tracker

06/30 6:17am ET

Abbott Laboratories (NYSE:ABT)

38.57
Delayed Data
As of Jun 29
 +1.01 / +2.69%
Today’s Change
36.00
Today|||52-Week Range
51.74
-14.12%
Year-to-Date
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content
Medtronic Acquires HeartWare With Some Activist Inspiration
Jun 27 / TheStreet.com - Paid Partner Content
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next?
Jun 17 / Zacks.com - Paid Partner Content
Becton Dickinson: 19% EPS Growth With Good Dividends
Jun 26 / GuruFocus News - Paid Partner Content
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Jun 17 / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: Intel Is Just Treading Water
Jun 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close37.56
Today’s open37.95
Day’s range37.95 - 38.75
Volume8,366,480
Average volume (3 months)9,187,055
Market cap$55.2B
Dividend yield2.70%
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)+18.14%
Earnings growth (this year)+2.62%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.78%
P/E ratio27.1
Price/Sales3.31
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.76+2.61%
CELGCelgene+1.53+1.57%
SHPGShire+9.66+5.65%
LLYEli Lilly and Co+3.00+3.99%
Data as of 06/29/2016

Financials

Next reporting dateJuly 13, 2016
EPS forecast (this quarter)$0.53
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts